Results 1 to 10 of about 59,485 (246)

Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma. [PDF]

Blood Cancer J
Zanwar S, Jevremovic D, Kapoor P, Olteanu H, Buadi F, Horna P, Gonsalves W, Seheult J, Otteson G, Hayman S, Abdallah N, Binder M, Cook J, Dispenzieri A, Dingli D, Dasari S, Gertz MA, Kourelis T, Leung N, Lin Y, Muchtar E, Siddiqui M, Weivoda M, Warsame R, Kyle RA, Rajkumar SV, Kumar S.   +26 more
europepmc   +1 more source

Citizens' participation in the Italian health-care system: the experience of the Mixed Advisory Committees. [PDF]

Health Expect, 2014
Serapioni M, Duxbury N.
europepmc   +1 more source

Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma. [PDF]

Blood Adv
Baek G, Varma G, Yamshon S, van Besien H, Bartlett NL, Watkins M, Shah HR, Baron K, Merryman RW, Falade AS, Svoboda J, Prischak S, D'Angelo C, Lukowski JD, Advani RH, Yeung AH, Rosenberg M, Voutsinas J, Di M, Lynch R, Poh C, Raghunathan V, Shadman M, Smith S, Till BG, Ujjani C, Diefenbach CS, Gopal AK.   +27 more
europepmc   +1 more source

Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes. [PDF]

Blood Cancer J
Zeidan AM, Santini V, Díez-Campelo M, Savona MR, Sekeres MA, Madanat YF, Fenaux P, Raza A, Mittelman M, Thépot S, Buckstein R, Germing U, Valcárcel D, Jonášová A, Shah S, Xia Q, Sun L, Navada S, Berry T, Platzbecker U, Komrokji RS.   +20 more
europepmc   +1 more source

Achieving effective medicines governance: guiding principles for the roles and responsibilities of Medicines and Therapeutics Committees in Australian hospitals. [PDF]

Intern Med J
Crisp L, Day R, Shutt A, Briggs J, Pulver L.   +4 more
europepmc   +1 more source

The UK Standing Dental Advisory Committee (1948-2010) with special reference to its Expert Working Party on Orthodontics, 1992. [PDF]

Br Dent J
Stephens C.
europepmc   +1 more source

Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation. [PDF]

Blood Adv
Aguirre LE, Kim HT, Elmariah H, Frumm SM, Kelkar AH, Ho V, Gooptu M, Koreth J, Shapiro RM, Romee R, Nikiforow S, Antin JH, Soiffer RJ, Shimony S, Luskin MR, Garcia JS, Chen EC, Wadleigh M, Winer ES, Stone RM, DeAngelo DJ, Al Ali N, Sallman D, Kuykendall A, Sweet K, Lancet JE, Padron E, Chan O, Xie Z, Cutler CS, Komrokji RS, Stahl M.   +31 more
europepmc   +1 more source

Reply: Metabolic Heterogeneity of Obesity and Outcome-Specific Effects of GLP-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome. [PDF]

JACC Adv
Kumar S, Anderson JE, Coviello A, Lopez-Jimenez F.   +3 more
europepmc   +1 more source

Secondary Prevention After Myocardial Infarction in the United States. [PDF]

J Am Coll Cardiol
Chiu N, Libby P, Gong J, Bhatt DL, Wadhera RK.   +4 more
europepmc   +1 more source

Enhancing the use of economic evidence in vaccination policy and decision making in low- and middle-income countries: a scoping review of existing strategies. [PDF]

BMJ Open
Okeke CC, Eze O, Ekwueme CN, Ezechukwu O, Mbachu CO, Uzochukwu B, Onwujekwe O.   +6 more
europepmc   +1 more source